Can measuring anticoagulant activity and concentration in the body play a role in clinical use of medicines used to prevent blood clots?
NewsCorporate
Hungarian is available via eTranslation, the European Commission's machine translation service.
Translate to Hungarian | Important information about machine translation
Registration opens for public workshop
The European Medicines Agency (EMA) is calling for expressions of interest from experts and stakeholders to attend a workshop on the role of pharmacokinetic and pharmacodynamic (PK/PD) measurements in the clinical use of direct oral anticoagulants (DOACs) scheduled to take place in London on 23 November 2015.
The Programme - Workshop on the role of pharmacokinetic and pharmacodynamic measurements in the use of direct oral anticoagulants of the workshop is available.
Expressions of interest should be sent to DOACworkshop@ema.europa.eu by Friday, 30 October 2015, including name, company or affiliation, telephone number and e-mail address.
The objectives of the workshop are to:
A total of 50 places are available. They will be allocated to ensure a fair representation across all stakeholder groups, including regulatory, patient and healthcare professionals and pharmaceutical industry representatives. Confirmation of participation in the workshop will be sent by 6 November 2015.
The workshop will be broadcast live on the EMA website. A video recording will be made available following the event. Presentations from the workshop will also be published.